-
3
-
-
10144258654
-
Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology
-
American Society of Clinical Oncology.
-
(1996)
J Clin Oncol
, vol.14
, pp. 2843-2877
-
-
-
4
-
-
0002409517
-
Results from a randomized adjuvant breast cancer study with high dose chemotherapy with CTCb supported by autologous bone marrow stem cells versus dose escalated and tailored FEC therapy
-
[abstract]
-
(1999)
Proc ASCO
, vol.18
, pp. 3
-
-
Bergh, J.1
-
5
-
-
0003344884
-
Randomised, controlled trial of high dose chemotherapy versus standard dose chemotherapy for high risk, surgically treated, primary breast cancer
-
[abstract]
-
(1999)
Proc ASCO
, vol.18
, pp. 4
-
-
Bezwoda, W.R.1
-
8
-
-
0033428408
-
The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black-White Cancer Survival Study
-
(1999)
Ethn Dis
, vol.9
, pp. 111-125
-
-
Breen, N.1
Wesley, M.N.2
Merrill, R.M.3
Johnson, K.4
-
17
-
-
0034690745
-
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials
-
Early Breast Cancer Trialists' Collaborative Group.
-
(2000)
Lancet
, vol.355
, pp. 1757-1770
-
-
-
18
-
-
0032537396
-
Tamoxifen for early breast cancer: An overview of the randomised trials
-
Early Breast Cancer Trialists' Collaborative Group.
-
(1998)
Lancet
, vol.351
, pp. 1451-1467
-
-
-
19
-
-
0032547564
-
Polychemotherapy for early breast cancer: An overview of the randomized trials
-
Early Breast Cancer Trialists' Collaborative Group.
-
(1998)
Lancet
, vol.352
, pp. 930-942
-
-
-
20
-
-
0029806829
-
Ovarian ablation in early breast cancer: Overview of the randomised trials
-
Early Breast Cancer Trialists' Collaborative Group.
-
(1996)
Lancet
, vol.348
, pp. 1189-1196
-
-
-
21
-
-
0028791012
-
Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials
-
Early Breast Cancer Trialists' Collaborative Group.
-
(1995)
N Engl J Med
, vol.333
, pp. 1444-1455
-
-
-
26
-
-
0025063119
-
Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients tumors: Results from the National Surgical Adjuvant Breast and Bowel Project B-15
-
(1990)
J Clin Oncol
, vol.8
, pp. 1483-1496
-
-
Fisher, B.1
Brown, A.M.2
Dimitrov, N.V.3
Poisson, R.4
Redmond, C.5
Margolese, R.G.6
-
32
-
-
8944231160
-
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: Eight-year results from National Surgical Adjuvant Breast and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil
-
(1996)
J Clin Oncol
, vol.14
, pp. 1982-1992
-
-
Fisher, B.1
Dignam, J.2
Mamounas, E.P.3
Costantino, J.P.4
Wickerham, D.L.5
Redmond, C.6
-
44
-
-
0032750091
-
High-dose chemotherapy for primary breast cancer: Facts versus anecdotes
-
(1999)
J Clin Oncol
, vol.17
, Issue.SUPPL. 11
, pp. 25-29
-
-
Hortobagyi, G.N.1
-
51
-
-
0031927983
-
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer
-
National Cancer Institute of Canada Clinical Trials Group.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2651-2658
-
-
Levine, M.N.1
Bramwell, V.H.2
Pritchard, K.I.3
Norris, B.D.4
Shepherd, L.E.5
Abu-Zahra, H.6
-
53
-
-
0030805625
-
Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel
-
NSABP Protocol B-27. (Huntingt)
-
(1997)
Oncology
, vol.11
, Issue.6 SUPPL. 6
, pp. 37-40
-
-
Mamounas, E.P.1
-
56
-
-
0004497294
-
Treatment of early stage breast cancer
-
National Institutes of Health Consensus Development Panel.
-
(1992)
J Natl Cancer Inst Monogr
, vol.11
, pp. 137-142
-
-
-
57
-
-
0022466504
-
National Institutes of Health Consensus Development Conference Statement: Adjuvant Chemotherapy for Breast Cancer
-
September 9-11, 1985
-
(1986)
CA Cancer J Clin
, vol.36
, pp. 42-47
-
-
-
72
-
-
0027263487
-
Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: The Scottish trial
-
Scottish Cancer Trials Breast Group and ICRF Breast Unit, Guy's Hospital, London.
-
(1993)
Lancet
, vol.341
, pp. 1293-1298
-
-
-
76
-
-
0029903614
-
Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
-
Swedish Breast Cancer Cooperative Group.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1543-1549
-
-
-
78
-
-
0029950085
-
Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 812-816
-
-
Tejeda, H.A.1
Green, S.B.2
Trimble, E.L.3
Ford, L.4
High, J.L.5
Ungerleider, R.S.6
-
80
-
-
0032538050
-
erb-B2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 1346-1360
-
-
Thor, A.D.1
Berry, D.A.2
Budman, D.R.3
Muss, H.B.4
Kute, T.5
Henderson, I.C.6
|